Cargando…
Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes
Glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-stimulated insulin secretion (GSIS). This response is blunted in type 2 diabetes (T2DM). Xenin-25 is a 25–amino acid neurotensin-related peptide that amplifies GIP-mediated GSIS in hyperglycemic mice. This study determines if xen...
Autores principales: | Wice, Burton M., Reeds, Dominic N., Tran, Hung D., Crimmins, Dan L., Patterson, Bruce W., Dunai, Judit, Wallendorf, Michael J., Ladenson, Jack H., Villareal, Dennis T., Polonsky, Kenneth S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379667/ https://www.ncbi.nlm.nih.gov/pubmed/22522617 http://dx.doi.org/10.2337/db11-1451 |
Ejemplares similares
-
Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance
por: Wang, Songyan, et al.
Publicado: (2018) -
Global Biochemical Profiling Identifies β-Hydroxypyruvate as a Potential Mediator of Type 2 Diabetes in Mice and Humans
por: Zhang, Sheng, et al.
Publicado: (2015) -
Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus
por: Chowdhury, Sara, et al.
Publicado: (2016) -
GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
por: Mentis, Nikolaos, et al.
Publicado: (2011) -
The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes
por: Woerle, Hans Juergen, et al.
Publicado: (2012)